Seasonal Variations in the Deoxypodophyllotoxin Content and Yield of Anthriscus sylvestris L. (Hoffm.) Grown in the Field and under Controlled ConditionsHENDRAWATI, Oktavia; WOERDENBAG, Herman J; HILLE, Jacques et al.Journal of agricultural and food chemistry (Print). 2011, Vol 59, Num 15, pp 8132-8139, issn 0021-8561, 8 p.Article

Influence of teniposide on platelet functions in vitroKUBISZ, P; SEGHIER, F; DOBROTORA, M et al.Thrombosis research. 1995, Vol 77, Num 2, pp 145-148, issn 0049-3848Article

Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cellsBAKHEET, S. A; ATTIA, S. M; AL-RASHEED, N. M et al.Mutagenesis. 2011, Vol 26, Num 4, pp 533-543, issn 0267-8357, 11 p.Article

INTERNATIONAL SYMPOSIUM ON THE PODOPHYLLOTOXINS IN CANCER THERAPY, SOUTHAMPTON, ENGLAND, JULY 8-9, 1981CARTER SK ED; MATHE G ED; MCELWAIN T ED et al.1982; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1982; VOL. 7; NO 2-3; 163 P.; BIBL. DISSEM.Conference Paper

Computerized dynamic voltammetric detection in high-performance liquid chromatography. I: On-line cyclic voltammetry of the antineoplastic agents etoposide and teniposidePLOEGMAKERS, H. H. J. L; MERTENS, M. J. M; VAN OORT, W. J et al.Analytica chimica acta. 1985, Vol 174, pp 71-82, issn 0003-2670Article

Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-dimethyl-1-O-(4,6-O-2-thenylidene-β-D-glucopyranosyl)epipodophyllotoxin (VM-26) in the treatment of primary and metastatic brain tumorsSTEWART, D. J; GRAHOVAC, Z; VANDENBERG, T et al.Neurosurgery. 1984, Vol 15, Num 6, pp 828-833, issn 0148-396XArticle

Comparative cytotoxic and cytokinetic effects of the epipodophyllotoxins 4'-demethylepipodophyllotoxin-9-(4,6-O-2-ethylidene-β-d-glucopyranoside) and 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-β-d-glucopyranoside) and their metabolites on human leukemic lymphoblasts = Effets cytotoxiques et cytocinétiques comparatifs des épipodophyllotoxines, 4'-déméthylépipodophyllotoxine-9-(4,6-O-2-éthylène-bêta-D-glucopyranoside) et 4'-déméthylépipodophyllotoxine-94,6-O-2-thénylidène-bêta-D-glucopyranosid et leurs métabolites sur les lymphoblastes leucémiques humainsDOW, L. W; SINKULE, J. A; LOOK, A. T et al.Cancer research (Baltimore). 1983, Vol 43, Num 12, pp 5699-5706, issn 0008-5472Article

Réaction de type anaphylactique après administration de téniposide : prudence chez les sujets atopiques = Anaphylactoid reaction to teniposide. Caution is warrarted in atopic patientsBAUDUER, F; DELMER, A; N'ZILA IBIASSI, J. P et al.La Semaine des hôpitaux de Paris. 1993, Vol 69, Num 29, pp 879-880, issn 0037-1777Article

TERATOGENIC AND CYTOGENIC EFFECTS OF SOME PLANT-DERIVED ANTITUMOR AGENTS (VINCRISTINE, COLCHICINE, MAYTANSINE, VP-16-213 AND VM-26) IN MICESIEBER SM; WHANG PENG J; BOTKIN C et al.1978; TERATOLOGY; USA; DA. 1978; VOL. 18; NO 1; PP. 31-48; BIBL. 1 P.Article

POLYCHIMIOTHERAPIE DES GLIOMES MALINS. RESULTATS PRELIMINAIRES D'UNE TRIPLE ASSOCIATIONCAUDRY M; RAGOT C; DILHUYDY JM et al.1976; BORDEAUX MED.; FR.; DA. 1976; VOL. 9; NO 10; PP. 747-758 (11P.); ABS. ALLEM. ESP. ITAL. ANGL.; BIBL. 1 P. 1/2Article

RESULTATS DU TRAITEMENT DU LYMPHOGRANULOME ET DE LA LEUCEMIE PAR UN DERIVE D'EPIPODOPHYLLOTOXINE ("VM26" SANDOZ)MILIC N; BORAS T; HANDL S et al.1975; AN. KLIN. BOLNICE "DR M. STOJANOVIC"; JUGOSL.; DA. 1975; VOL. 14; NO 1; PP. 35-45; ABS. ANGL.; BIBL. 12 REF.Article

VM 26-INDUCED CHANGES IN HEPATIC INTERMEDIARY METABOLISM OF MICE.HACKER M; ROBERTS D.1977; CANCER RES.; U.S.A.; DA. 1977; VOL. 37; NO 9; PP. 3287-3292; BIBL. 9 REF.Article

ESSAI DE TRAITEMENT DES GLIOBLASTOMES DE L'ADULTE ET DES METASTASES CEREBRALES PAR L'ASSOCIATION D'ADRIAMYCINE, DE VM 26 ET DE CCNU. RESULTATS D'UN ESSAI DE TYPE IIPOUILLART P; MATHE G; POISSON M et al.1976; NOUV. PRESSE MED.; FR.; DA. 1976; VOL. 5; NO 25; PP. 1571-1576; ABS. ANGL.; BIBL. 24 REF.Article

COMPARISON OF THE HUMAN PHARMACOKINETICS OF VM-26 AND VP-16, TWO ANTINEOPLASTIC EPIPODOPHYLLOTOXIN GLUCOPYRANOSIDE DERIVATIVES.ALLEN LM; CREAVEN PJ.1975; EUROP. J. CANCER; G.B.; DA. 1975; VOL. 11; NO 10; PP. 697-707; BIBL. 2 P. 1/2Article

PTG, A NEW ANTINEOPLASTIC EPIPODOPHYLLOTOXIN.CREAVEN PJ; ALLEN LM.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 2; PP. 227-233; BIBL. 12 REF.Article

Combination chemotherapy with cisplatin and VM-26 in advanced transitional cell carcinoma of the bladder = Association de cis-platine et de VM-26 dans le traitement des cancers avancés à cellules transitionnelles de la vessieSTOTER, G; VAN OOSTEROM, A. T; MULDER, J. H et al.European journal of cancer & clinical oncology. 1984, Vol 20, Num 3, pp 315-317, issn 0277-5379Article

Molecular cytogenetic evaluation of the aneugenic effects of teniposide in somatic and germinal cells of male miceATTIA, Sabry M.Mutagenesis. 2012, Vol 27, Num 1, pp 31-39, issn 0267-8357, 9 p.Article

Antitumor properties of podophyllotoxin and related compoundsM.GORDALIZA; CASTRO, M. A; DEL CORRAL, J. M et al.Current pharmaceutical design. 2000, Vol 6, Num 18, pp 1811-1839, issn 1381-6128Article

Cyclosporin A as a multidrug-resistant modulator in patients with renal cell carcinoma treated with teniposideTOFFOLI, G; SORIO, R; GIGANTE, M et al.British journal of cancer. 1997, Vol 75, Num 5, pp 715-721, issn 0007-0920Article

Chemical Stability of Teniposide in Aqueous and Parenteral Lipid EmulsionsJING WANG; YUE CUI; XING TANG et al.Drug development and industrial pharmacy. 2009, Vol 35, Num 4, pp 508-513, issn 0363-9045, 6 p.Article

Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavageROSS, W; ROWE, T; GLISSON, B et al.Cancer research (Baltimore). 1984, Vol 44, Num 12, pp 5857-5860, issn 0008-5472, 1Article

DIE WIRKUNG KOMBINIERTER CHEMOTHERAPIE (ADRIAMYCIN/VM26/CCNU) BEI HIRNEIGENEN TUMOREN DES ESWACHSENENALTERS UND IM TIEREXPERIMENT = EFFETS D'UNE CHIMIOTHERAPIE ASSOCIEE (ADRIAMYCINE/VM26/CCNU) DANS DES TUMEURS INTRACRANIENNES CHEZ L'ADULTE ET EN EXPERIMENTATION ANIMALEILSEN HW; PETROVICI IN; MENNEL HD et al.1982; FORTSCHR. NEUROL. PSYCHIATR.; ISSN 0720-4299; DEU; DA. 1982; VOL. 50; NO 3; PP. 73-90; ABS. ENG; BIBL. 41 REF.Article

COMBINATION CHEMOTHERAPY WITH VM26 AND CCNU IN PRIMARY MALIGNANT BRAIN TUMORS OF CHILDRENSEILER RW.1980; HELV. PAEDIATR. ACTA; CHE; DA. 1980; VOL. 35; NO 1; PP. 51-56; ABS. GER/FRE; BIBL. 7 REF.Article

PULMONARY HYALINE MEMBRANE DISEASE OCCURRING IN THE COURSE OF VM-26 THERAPYCOMMERS JR; FOLEY JF.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 11-12; PP. 2093-2095; BIBL. 12 REF.Article

CANCER DU REIN: ESSAI DE CHIMIOTHERAPIE: 97 MALADESAMIEL JL; CUKIER J; DROZ JP et al.1979; NOUV. PRESSE MED.; FRA; DA. 1979; VOL. 8; NO 28; PP. 2335-2337; ABS. ENG; BIBL. 19 REF.Article